Literature DB >> 27777096

Impact of Fibromyalgia in the Sit-to-Stand-to-Sit Performance Compared With Healthy Controls.

Daniel Collado-Mateo1, Jose C Adsuar2, Francisco J Dominguez-Muñoz3, Pedro R Olivares4, Narcis Gusi5.   

Abstract

BACKGROUND: Fibromyalgia is associated with a reduction in the ability to perform activities of daily living. Sit-to-stand-to-sit performance is one of the most common activities of daily living and often is evaluated by counting the number of repetitions of the 30-second chair-stand test. No study, however, has examined the performance over the 30 seconds of this test of female patients with fibromyalgia on a phase-by-phase basis.
OBJECTIVE: To evaluate the impact of fibromyalgia on performance of the 30-second chair-stand test and to analyze how the kinematic performance changed over the 30-second test period.
DESIGN: A cross-sectional study.
SETTING: Local association of fibromyalgia. PARTICIPANTS: Fifteen females with fibromyalgia and nine healthy female controls. INTERVENTION: Participants performed the 30-second chair-stand test while wearing a motion capture device. MAIN OUTCOME MEASURE: Duration of each sit-to-stand-to-sit phase within the 30-second time limit was compared between groups using repeated measures analysis of variance. The association between duration of phases and scores from the revised version of the Fibromyalgia Impact Questionnaire was tested using bivariate correlations.
RESULTS: The duration of impulse and sit-to-stand phases were gradually increased over the 30 seconds of the chair-stand test for women with fibromyalgia compared with healthy controls (P = .04 and P = .02, respectively). The mean duration of these 2 phases was associated with symptom duration and the function domain of the revised version of the Fibromyalgia Impact Questionnaire (P < .05). Also, stiffness was directly associated with the duration of the stand-up phase (P = .04).
CONCLUSION: Kinematic performance during the 30-second chair-stand test differed between women with fibromyalgia and healthy controls. Since sit-to-stand from a chair is a common daily activity, women with fibromyalgia may require specific exercises to improve performance of this task. LEVEL OF EVIDENCE: Not applicable.
Copyright © 2017 American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27777096     DOI: 10.1016/j.pmrj.2016.10.006

Source DB:  PubMed          Journal:  PM R        ISSN: 1934-1482            Impact factor:   2.298


  3 in total

1.  Oxidative Stress Biomarkers and Quality of Life Are Contributing Factors of Muscle Pain and Lean Body Mass in Patients with Fibromyalgia.

Authors:  Jousielle Márcia Dos Santos; Ana Cristina Rodrigues Lacerda; Vanessa Gonçalves César Ribeiro; Pedro Henrique Scheidt Figueiredo; Sueli Ferreira Fonseca; Vanessa Kelly da Silva Lage; Henrique Silveira Costa; Vanessa Pereira Lima; Borja Sañudo; Mário Bernardo-Filho; Danúbia da Cunha de Sá Caputo; Vanessa Amaral Mendonça; Redha Taiar
Journal:  Biology (Basel)       Date:  2022-06-19

2.  Reliability of the 30 s Chair Stand Test in Women with Fibromyalgia.

Authors:  Juan Pedro Martín-Martínez; Daniel Collado-Mateo; Francisco Javier Domínguez-Muñoz; Santos Villafaina; Narcís Gusi; Jorge Pérez-Gómez
Journal:  Int J Environ Res Public Health       Date:  2019-07-02       Impact factor: 3.390

3.  Efficacy of Whole-Body Vibration Training on Brain-Derived Neurotrophic Factor, Clinical and Functional Outcomes, and Quality of Life in Women with Fibromyalgia Syndrome: A Randomized Controlled Trial.

Authors:  Vanessa G C Ribeiro; Ana C R Lacerda; Jousielle M Santos; Ana C Coelho-Oliveira; Sueli F Fonseca; Ana C N Prates; Jurandir Flor; Bruna C C Garcia; Rosalina Tossige-Gomes; Hércules R Leite; José S C Fernandes; Arthur N Arrieiro; Alessandro Sartorio; Borja Sañudo; Danubia C Sá-Caputo; Mário Bernardo-Filho; Pedro H S Figueiredo; Henrique S Costa; Vanessa P Lima; Renato F Cardoso; Alessandra C Bastone; Luana A Soares; Vanessa A Mendonça; Redha Taiar
Journal:  J Healthc Eng       Date:  2021-11-30       Impact factor: 2.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.